In leukemia, blocking of the CD70-CD27 interaction in CML [21], AML [12], B-ALL [22] and some cases of B-CLL [51] reduced proliferation of the malignant cells. This evidence concerns the gene CD70 and chronic myelogenous leukemia, BCR-ABL1 positive.